TW201541078A - A health indicator - Google Patents
A health indicator Download PDFInfo
- Publication number
- TW201541078A TW201541078A TW103114412A TW103114412A TW201541078A TW 201541078 A TW201541078 A TW 201541078A TW 103114412 A TW103114412 A TW 103114412A TW 103114412 A TW103114412 A TW 103114412A TW 201541078 A TW201541078 A TW 201541078A
- Authority
- TW
- Taiwan
- Prior art keywords
- human health
- health indicator
- indicator
- acid
- thickener
- Prior art date
Links
Abstract
Description
一種人體健康指示劑，特別係一種用於檢測人體排泄物之人體健康指示劑。 A human health indicator, in particular, a human health indicator for detecting human excrement.
有進有出，為人體代謝的主要法則，攝入的食物經過消化系統的處理後，必須將代謝後的廢物排出身體外，因此，「排泄」是人體每日所必要進行的大事。然而，現代人生活壓力大，生活的步調隨著繁忙的工作以及沉重的家庭生計而加快著，排泄雖說是人們日常生活中密不可分的一環，但卻往往被視為必須快速解決的例行公事。 There are some rules for the metabolism of the human body. The foods that have been ingested must be discharged from the body after being treated by the digestive system. Therefore, "excretion" is a major event that the human body needs every day. However, modern people are under great pressure in life, and the pace of life is accelerating with busy work and heavy family livelihood. Although excretion is an inseparable part of people's daily life, it is often regarded as a routine that must be resolved quickly.
值得注意的是，根據醫學研究指出排泄物的性質會反映出人體的健康狀況。一般健康的人體應會排泄出平滑緻密且含水量約70%的軟糞便，而糞便呈現淡棕色，另外，健康人類所排出的尿液顏色應為淡黃色或琥珀色，且酸鹼值呈現約為pH6.0~6.5弱酸性。但，糖尿病、痛風或白血病的患者卻可能排出偏酸性的尿液，偏酸的尿液亦有可能反映出身體之泌尿道遭到大腸桿菌的感染，而膀胱炎患者則傾向排出偏鹼的尿液，偏鹼的尿液則有可能是變形桿菌造成的泌尿道感染之徵兆。 It is worth noting that according to medical research, the nature of excreta reflects the health of the human body. Generally, a healthy human body should excrete soft stools that are smooth and dense with a water content of about 70%, while the stools are light brown. In addition, the color of urine discharged by healthy humans should be light yellow or amber, and the pH value is about It is weakly acidic at pH 6.0~6.5. However, patients with diabetes, gout or leukemia may expel acidic urine. Acidic urine may also reflect the infection of the body's urinary tract by E. coli, while patients with cystitis tend to expel alkaline urine. Liquid, alkaline urine may be a sign of urinary tract infection caused by Proteus.
除此之外，當民眾坐在馬桶上進行排泄時，排泄物落入馬桶水中會造成聲響，常令使用者感到十分地難為情，而排泄物落入馬桶的同時可能對馬桶水造成衝擊，使馬桶水噴濺而上碰觸到臀部的皮膚，如此一來，不但不衛生，亦降低了如廁的舒適度。 In addition, when the people sit on the toilet for excretion, the discharge of the excrement into the toilet water will cause a sound, which often makes the user feel very embarrassed, and the excrement may cause impact on the toilet water while falling into the toilet. The toilet water splashes and touches the skin of the buttocks, which is not only unsanitary, but also reduces the comfort of the toilet.
有鑑於此，有必要提供一種人體健康指示劑，該人體健康指示劑係可以溶於馬桶水中，用以檢測排泄物的特性，使民眾便捷且衛生地從排泄物中獲得有用的健康指示資訊，同時，該人體健康指示劑亦能減緩排泄物落入水的速度及衝擊，進而增加使用者的如廁舒適度。 In view of the above, it is necessary to provide a human health indicator which can be dissolved in the toilet water to detect the characteristics of the excrement, so that the public can obtain useful health indication information from the excrement conveniently and hygienically. At the same time, the human health indicator can also slow down the speed and impact of the waste falling into the water, thereby increasing the user's toilet comfort.
本發明之主要目的係為提供一種人體健康指示劑，係可以檢測排泄物的特性，以使民眾便捷且衛生地從排泄物中獲得有用的健康指示資訊者。 The main object of the present invention is to provide a human health indicator which is capable of detecting the characteristics of excrement so that the public can obtain useful health indication information from the excrement conveniently and hygienically.
本發明之次要目的係為提供一種人體健康指示劑，係可以降低排泄物落入水的速度及衝擊，進而增加使用者的如廁舒適度者。 A secondary object of the present invention is to provide a human health indicator which can reduce the speed and impact of excrement falling into water, thereby increasing the user's toilet comfort.
為達到前述發明目的，本發明所運用之技術手段及藉由該技術手段所能達到之功效包含有：一種人體健康指示劑，係包含：以重量百分比計為3~6%之一酸鹼指示劑、15~26%之一增稠劑以及68~82%之一助溶劑。 In order to achieve the foregoing object, the technical means and the efficiencies achievable by the technical method include: a human health indicator comprising: an acid-base indicator of 3 to 6% by weight. A dose of 15~26% thickener and 68~82% of a co-solvent.
本發明之人體健康指示劑，其中，該人體健康指示劑係包含以重量百分比計為3.8%之該酸鹼指示劑、20.6%之該增稠劑以及75.6%之該助溶劑。 The human health indicator of the present invention, wherein the human health indicator comprises 3.8% by weight of the acid-base indicator, 20.6% of the thickener, and 75.6% of the co-solvent.
本發明之人體健康指示劑，其中，酸鹼指示劑係選自由酚酞、溴百里酚藍、溴酚藍或甲基紅所組成之群組。 The human health indicator of the present invention, wherein the acid-base indicator is selected from the group consisting of phenolphthalein, bromothymol blue, bromophenol blue or methyl red.
本發明之人體健康指示劑，其中，該酸鹼指示劑係為酚酞：溴百里酚藍：溴酚藍：甲基紅為6.5：4.5：1：2的重量比例混合而成。 The human health indicator of the present invention, wherein the acid-base indicator is a mixture of phenolphthalein: bromothymol blue: bromophenol blue: methyl red in a weight ratio of 6.5:4.5:1:2.
本發明之人體健康指示劑，其中，該增稠劑為玉米粉、羥丙基甲基纖維素、黃原膠、海藻酸鈉、卡拉膠、明膠、果膠或瓊脂粉。 The human health indicator of the present invention, wherein the thickener is corn flour, hydroxypropyl methylcellulose, xanthan gum, sodium alginate, carrageenan, gelatin, pectin or agar powder.
本發明之人體健康指示劑，其中，該助溶劑係選自碳酸氫鈉、檸檬酸或氯化鈉組成之群組。 The human health indicator of the present invention, wherein the co-solvent is selected from the group consisting of sodium hydrogencarbonate, citric acid or sodium chloride.
本發明之人體健康指示劑，其中，該助溶劑係為碳酸氫鈉：檸檬酸：氯化鈉以2.67：1：1.25的重量比例混合而成。 The human health indicator of the present invention, wherein the cosolvent is sodium hydrogencarbonate: citric acid: sodium chloride is mixed in a weight ratio of 2.67:1:1.25.
本發明之人體健康指示劑，其中，該酸鹼指示劑為酚酞、溴百里酚藍、溴酚藍以及甲基紅，該增稠劑為玉米粉，該助溶劑為碳酸氫鈉、檸檬酸及氯化鈉，該人體健康指示劑之製備方式係包含：將1.3g之酚酞、0.9g溴百里酚藍、0.2g溴酚藍以及0.4g之甲基紅混合均勻，以獲得一酸鹼指示劑；將2g之碳酸氫鈉以及1g之玉米粉混合均勻，並加入0.5ml的水混合以獲得一第一粉末；而後將3.2g之該第一粉末與0.8g之檸檬酸混合攪拌均勻，以獲得一第二粉末；將0.2g之該酸鹼指示劑及4g之該第二粉末與1g之氯化鈉混合均勻，以獲得該人體健康指示劑。 The human health indicator of the present invention, wherein the acid-base indicator is phenolphthalein, bromothymol blue, bromophenol blue and methyl red, the thickener is corn flour, and the cosolvent is sodium hydrogencarbonate and citric acid. And sodium chloride, the human health indicator is prepared by mixing 1.3 g of phenolphthalein, 0.9 g of bromothymol blue, 0.2 g of bromophenol blue and 0.4 g of methyl red to obtain an acid-base. An indicator; 2 g of sodium hydrogencarbonate and 1 g of corn flour are uniformly mixed, and 0.5 ml of water is added to obtain a first powder; then 3.2 g of the first powder is mixed with 0.8 g of citric acid and stirred uniformly. A second powder was obtained; 0.2 g of the acid-base indicator and 4 g of the second powder were uniformly mixed with 1 g of sodium chloride to obtain the human health indicator.
本發明之人體健康指示劑，其中，該增稠劑及該助溶劑混合後之酸鹼值呈中性。 The human health indicator of the present invention, wherein the pH value of the thickener and the co-solvent after mixing is neutral.
本發明之人體健康指示劑，其中，該人體健康指示劑呈現錠狀。 The human health indicator of the present invention, wherein the human health indicator is in the form of a tablet.
本發明之人體健康指示劑，其中，該人體健康指示劑放入一模具並施予6000~7000psi的壓力後，靜置10~30分鐘，使該人體健康指示劑壓製成錠狀。 The human health indicator of the present invention, wherein the human health indicator is placed in a mold and subjected to a pressure of 6000 to 7000 psi, and then allowed to stand for 10 to 30 minutes to press the human health indicator into a tablet shape.
本發明之人體健康指示劑，係包含有該酸鹼指示劑的成分，使用者僅需將該人體健康指示劑放入馬桶中，待人體健康指示劑溶解後即可用以檢測排泄物的酸鹼度，進而達到使民眾便捷且衛生地從排泄物中獲得有用的健康指示資訊之功效。 The human health indicator of the present invention comprises the component of the acid-base indicator, and the user only needs to put the human health indicator into the toilet, and the human health indicator can be used to detect the pH of the excrement after being dissolved. In turn, it achieves the effect of enabling the public to obtain useful health instruction information from the excrement conveniently and hygienically.
本發明之人體健康指示劑，係含有該增稠劑，該增稠劑會提高水的稠度，以使該人體健康指示劑之水溶液能有效減緩物體落入的速度，故，將該人體健康指示劑實際溶解於馬桶水中時，可降低排泄物落入水的速度及衝擊，不但降低排泄物落水時所產生的聲響，更可避免馬桶水 噴濺而接觸到臀部皮膚，進而達到增加使用者的如廁舒適度之功效。 The human health indicator of the present invention contains the thickener, and the thickener increases the consistency of the water, so that the aqueous solution of the human health indicator can effectively slow down the falling of the object, so the human health indication When the agent is actually dissolved in the toilet water, it can reduce the speed and impact of the waste falling into the water, not only reduce the sound generated when the excrement falls, but also avoid the toilet water. Splashing and touching the skin of the buttocks, thereby increasing the user's toilet comfort.
為讓本發明之上述及其他目的、特徵及優點能更明顯易懂，下文特舉本發明之較佳實施例，並配合所附圖式，作詳細說明如下：本發明之人體健康指示劑係包含以重量百分比計為3~6%之一酸鹼指示劑、15~26%之一增稠劑以及68~82%之一助溶劑。 The above and other objects, features and advantages of the present invention will become more <RTIgt; It comprises 3 to 6% by weight of a pH indicator, 15 to 26% of a thickener and 68 to 82% of a cosolvent.
詳而言之，該酸鹼指示劑係選自由酚酞(3,3-Bis(4-hydroxyphenyl)-1(3H)-isobenzofuranone)、溴百里酚藍(4,4'-(3H-2,1 Benzoxathiol-3-ylidene)bis [2 bromo-3-methyl-6-(1-methylethyl)phenol]S,S-dioxide)、溴酚藍(2,6-dibromo-4-[3-(3,5-dibromo-4-hydroxyphenyl)-1,1-dioxo-3-benzo[c]oxat hiolyl]phenol)或甲基紅(2-{[4-(dimethylamino)phenyl]diazenyl}benzoic acid)所組成之群組，該酸鹼指示劑係用以檢測排泄物的酸鹼值，以提供身體狀況的酸鹼度資訊。於本實施例中，該酸鹼指示劑為酚酞：溴百里酚藍：溴酚藍：甲基紅以重量比計為6.5：4.5：1：2所組成。 In detail, the acid-base indicator is selected from the group consisting of bismuth (3,3-Bis(4-hydroxyphenyl)-1(3H)-isobenzofuranone) and bromothymol blue (4,4'-(3H-2, 1 Benzoxathiol-3-ylidene)bis [2 bromo-3-methyl-6-(1-methylethyl)phenol]S, S-dioxide), bromophenol blue (2,6-dibromo-4-[3-(3, 5-dibromo-4-hydroxyphenyl)-1,1-dioxo-3-benzo[c]oxat hiolyl]phenol) or methyl red (2-{[4-(dimethylamino)phenyl]diazenyl}benzoic acid) In the group, the acid-base indicator is used to detect the pH value of the excrement to provide information on the pH of the body condition. In the present embodiment, the acid-base indicator is phenolphthalein: bromothymol blue: bromophenol blue: methyl red is composed of 6.5:4.5:1:2 by weight.
該增稠劑係可以為玉米粉、黃原膠、海藻酸鈉、卡拉膠、明膠、果膠、瓊脂粉或羥丙基甲基纖維素等，該增稠劑能增加馬桶水的稠度，減緩排泄物落入馬桶水中的衝擊，以防止馬桶水因排泄物落入而造成噴濺。於本實施例中，該增稠劑係為玉米粉。 The thickening agent may be corn flour, xanthan gum, sodium alginate, carrageenan, gelatin, pectin, agar powder or hydroxypropyl methylcellulose, etc., the thickener can increase the consistency of the toilet water and slow down The impact of the waste into the toilet water to prevent the toilet water from splashing due to the falling of the waste. In this embodiment, the thickener is corn flour.
該助溶劑係可以選自由檸檬酸、碳酸氫鈉或氯化鈉所組成之群組，該助溶劑係用以幫助該酸鹼指示劑及該增稠劑更容易與水互溶，以增加該人體健康指示劑溶解於水中的速率。於本實施例中，該助溶劑係為碳酸氫鈉：檸檬酸：氯化鈉以2.67：1：1.25之重量比所組成。 The co-solvent may be selected from the group consisting of citric acid, sodium bicarbonate or sodium chloride, which is used to help the acid-base indicator and the thickener to be more miscible with water to increase the body. The rate at which the health indicator dissolves in water. In the present embodiment, the co-solvent is composed of sodium hydrogencarbonate: citric acid: sodium chloride in a weight ratio of 2.67:1:1.25.
較佳地，另可以藉由調整該增稠劑及該助溶劑的重量比，使該增稠劑及該助溶劑混合後呈為中性，以確保該人體健康指示劑可確實反映出待測物之酸鹼值，於本實施例中，係利用調整玉米粉：碳酸氫納：檸檬酸之重量比為1.25：2.67：1，以使該增稠劑與該助溶劑混合後呈中性。 Preferably, the thickener and the co-solvent are mixed to be neutral after adjusting the weight ratio of the thickener and the co-solvent to ensure that the human health indicator can accurately reflect the test. In the present embodiment, the pH value of the corn flour: sodium bicarbonate: citric acid is 1.25: 2.67:1, so that the thickener is neutral after being mixed with the co-solvent.
於本實施例中，係先將1.3g之酚酞、0.9g溴百里酚藍、0.2g溴酚藍以及0.4g之甲基紅混合均勻，以獲得赭紅色之該酸鹼指示劑；在此同時，將2g之碳酸氫鈉以及1g之玉米粉混合均勻，並添加0.5ml的水以增加玉米粉之附著力，以獲得一第一粉末；而後將3.2g之該第一粉末與0.8g之檸檬酸混合攪拌均勻，以獲得一第二粉末；最後，將0.2g之該酸鹼指示劑及4g之該第二粉末與1g之氯化鈉混合均勻，即獲得本發明之該人體健康指示劑。 In this embodiment, 1.3 g of phenolphthalein, 0.9 g of bromothymol blue, 0.2 g of bromophenol blue, and 0.4 g of methyl red are uniformly mixed to obtain an acid-base indicator of magenta; At the same time, 2 g of sodium hydrogencarbonate and 1 g of corn flour were uniformly mixed, and 0.5 ml of water was added to increase the adhesion of the corn flour to obtain a first powder; then 3.2 g of the first powder and 0.8 g of the same The citric acid is mixed and stirred uniformly to obtain a second powder; finally, 0.2 g of the acid-base indicator and 4 g of the second powder are uniformly mixed with 1 g of sodium chloride to obtain the human health indicator of the present invention. .
承上述，本實施例之該人體健康指示劑係包含以重量百分比計為3.8%之該酸鹼指示劑、20.6%之該增稠劑以及75.6%之該助溶劑，其中，該酸鹼指示劑則為酚酞：溴百里酚藍：溴酚藍：甲基紅為6.5：4.5：1：2的重量比例混合而成，該增稠劑係為玉米粉，而該助溶劑係為碳酸氫鈉：檸檬酸；氯化鈉以2.67：1：1.25的重量比例混合而成。 In the above, the human health indicator of the present embodiment comprises 3.8% by weight of the acid-base indicator, 20.6% of the thickener and 75.6% of the co-solvent, wherein the acid-base indicator Then, it is a mixture of phenolphthalein: bromothymol blue: bromophenol blue: methyl red is 6.5:4.5:1:2, the thickener is corn flour, and the cosolvent is sodium hydrogencarbonate. : citric acid; sodium chloride is mixed in a weight ratio of 2.67:1:1.25.
較佳地，於本實施例中，將該酸鹼指示劑、該增稠劑及該助溶劑混合均勻，並將得到之該人體健康指示劑放入一模具中，施予一6500psi的壓力後，靜置10~30分鐘，使該人體健康指示劑壓製成錠狀，以方便使用者取用。(實施例中，壓力應該是一個明確值而非範圍，請提供一個明確值ex：6500psi) Preferably, in this embodiment, the acid-base indicator, the thickener and the co-solvent are uniformly mixed, and the obtained human health indicator is placed in a mold and subjected to a pressure of 6,500 psi. After standing for 10 to 30 minutes, the human health indicator is pressed into an ingot shape for the convenience of the user. (In the example, the pressure should be a clear value rather than a range, please provide a clear value ex: 6500psi)
為了證實本發明之健康指示劑確實能用以檢測排泄物之酸鹼值，以提供使用者健康資訊，故先對本實施例中所調配之該酸鹼指示劑進行變色範圍測試，詳列於表一。 In order to prove that the health indicator of the present invention can be used to detect the pH value of the excrement to provide user health information, the color-acid indicator of the acid-base indicator formulated in the present embodiment is tested first, as shown in the table. One.
表一：該酸鹼指示劑之變色範圍測試結果
由表一可知，該酸鹼指示劑具有相當寬廣的變色範圍，可清楚辨別pH4到pH10的樣品之酸鹼值。 As can be seen from Table 1, the acid-base indicator has a relatively wide range of discoloration, and the pH value of the sample from pH 4 to pH 10 can be clearly discerned.
接著，進行該人體健康指示變色實驗。此變色實驗係分別將不同劑量之該人體健康指示劑溶入固定體積之水中，以調配出不同濃度淡酸鹼值皆固定於pH7之該人體健康指示劑，並將尿液、弱酸性樣品(pH 6)以及弱鹼性樣品(pH 8)分別倒入同一濃度之該人體健康指示劑進行測試，詳列於表二。 Next, the human health indicator color change experiment was performed. The color change experiment separately dissolves different doses of the human health indicator into a fixed volume of water to formulate the human health indicator with different concentrations of pale acid and alkali values fixed at pH 7, and urine and weakly acidic samples ( The pH 6) and the weakly alkaline sample (pH 8) were respectively poured into the same concentration of the human health indicator for testing, as detailed in Table 2.
由表二的實驗數據可得知：當該人體健康指示劑濃度為0.1g/L以及0.25g/L時，三個樣品皆呈現相同的顏色，顯示該人體健康指示劑的濃度並不適宜用以辨別尿液之酸鹼度，而當該人體健康指示劑濃度為0.15g/L以及0.2g/L時，尿液、弱酸性樣品(pH 6)以及弱鹼性樣品(pH 8)則可由顏色清楚的辨識出來。此變色實驗不僅定出該人體健康指示劑較佳之操作濃度為0.15~0.2g/L，由該人體健康指示劑對尿液、弱酸性樣品以及弱鹼性樣品所呈現的顏色差異，更顯示出該人體健康指示劑用於判 別尿液的酸鹼度具有鑑別度。 From the experimental data in Table 2, it can be known that when the concentration of the human health indicator is 0.1 g/L and 0.25 g/L, all the three samples exhibit the same color, indicating that the concentration of the human health indicator is not suitable. To determine the pH of the urine, and when the concentration of the human health indicator is 0.15g/L and 0.2g/L, the urine, the weakly acidic sample (pH 6) and the weakly alkaline sample (pH 8) can be clearly colored. Recognized. The color change experiment not only determines that the human body health indicator has a preferred operating concentration of 0.15 to 0.2 g/L, but also shows the difference in color exhibited by the human health indicator for urine, weakly acidic samples, and weakly alkaline samples. The human health indicator is used to judge The pH of the urine is discriminating.
為了證實本發明之健康指示劑確實能降低排泄物落入水的速度及衝擊，故進行了沉降實驗。此沉降實驗為利用聚乳酸(polyactic acid,PLA)材質的BB彈，分別放入自來水以及該人體健康指示劑之水溶液，測試BB彈在兩種不同液體中的沉降速率變化。所使用的BB彈之直徑為6mm，重量為0.12g，體積為113mm3，密度則是1.06g/m3，係使用500ml量筒，並分別將自來水以及健康指示劑溶液倒入500ml量筒中，至量筒刻度為35cm，在此，健康指示劑溶液係為1g之人體健康指示劑溶於500ml的自來水中所調配而成，實驗結果詳列於表三。 In order to confirm that the health indicator of the present invention can actually reduce the rate and impact of excrement falling into water, a sedimentation experiment was carried out. The sedimentation experiment was carried out by using a BB bomb made of polyactic acid (PLA), and separately adding tap water and an aqueous solution of the human health indicator to test the sedimentation rate change of the BB bomb in two different liquids. The BB bomb used has a diameter of 6 mm, a weight of 0.12 g, a volume of 113 mm 3 , and a density of 1.06 g/m 3 . A 500 ml measuring cylinder is used, and the tap water and the health indicator solution are respectively poured into a 500 ml measuring cylinder to The cylinder scale is 35 cm. Here, the health indicator solution is prepared by dissolving 1 g of the human health indicator in 500 ml of tap water. The experimental results are detailed in Table 3.
在沉降實驗當中，BB彈即模擬人體的排泄物，由實驗結果 發現，使用本發明之該人體健康指示劑之水溶液，相對於一般的自來水可有效的降低BB彈的沉降速率(15.63cm/s降至11.49cm/s)，當BB彈的沉降速率降低時，即可減緩物體落入水中所造成的衝擊力。因此，由沉降實驗之結果可知：當該人體健康指示劑之溶液實際取代一般自來水作為馬桶水時，可有效降低排泄物落入馬桶水的衝擊，防止馬桶水於排泄物落入後造成噴濺。 In the sedimentation experiment, the BB bomb simulates the excrement of the human body, and the experimental results It has been found that using the aqueous solution of the human health indicator of the present invention can effectively reduce the sedimentation rate of the BB bomb (15.63 cm/s to 11.49 cm/s) relative to the general tap water, and when the sedimentation rate of the BB bomb is lowered, It can slow down the impact of objects falling into the water. Therefore, from the results of the sedimentation experiment, it can be known that when the solution of the human health indicator actually replaces the general tap water as the toilet water, the impact of the excrement falling into the toilet water can be effectively reduced, and the toilet water can be prevented from splashing after the excrement falls. .
綜上所述，本發明之健康指示劑因包含有該酸鹼指示劑的成分，使用者僅需將該人體健康指示劑放入馬桶中，待人體健康指示劑溶解後即可用以檢測排泄物的酸鹼度，進而達到使民眾便捷且衛生地從排泄物中獲得有用的健康指示資訊之功效。 In summary, the health indicator of the present invention contains the component of the acid-base indicator, and the user only needs to put the human health indicator into the toilet, and the human health indicator can be used to detect the excrement after being dissolved. The pH, in turn, achieves the benefits of providing people with convenient and hygienic access to useful health instructions from the feces.
另外，由於該人體健康指示劑係含有該增稠劑，當該人體健康指示劑溶入水中時，該增稠劑會提高水的稠度，以使該人體健康指示劑之水溶液能有效減緩物體落入的速度，故，將該人體健康指示劑實際溶解於馬桶水中時，可降低排泄物落入水的速度及衝擊，不但降低排泄物落水時所產生的聲響，更可避免馬桶水噴濺而接觸到臀部皮膚，進而達到增加使用者的如廁舒適度之功效。 In addition, since the human health indicator contains the thickener, when the human health indicator is dissolved in water, the thickener increases the consistency of the water, so that the aqueous solution of the human health indicator can effectively slow down the object. The speed of entry, therefore, when the human health indicator is actually dissolved in the toilet water, the speed and impact of the waste falling into the water can be reduced, not only the sound generated when the excrement falls, but also the splash of the toilet water can be avoided. Contact with the skin of the buttocks to achieve the effect of increasing the user's toilet comfort.
雖然本發明已利用上述較佳實施例揭示，然其並非用以限定本發明，任何熟習此技藝者在不脫離本發明之精神和範圍之內，相對上述實施例進行各種更動與修改仍屬本發明所保護之技術範疇，因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 While the invention has been described in connection with the preferred embodiments described above, it is not intended to limit the scope of the invention. The technical scope of the invention is protected, and therefore the scope of the invention is defined by the scope of the appended claims.
Claims (11)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW103114412A TWI611184B (en) | 2014-04-21 | 2014-04-21 | Method for using health indicator |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW103114412A TWI611184B (en) | 2014-04-21 | 2014-04-21 | Method for using health indicator |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201541078A true TW201541078A (en) | 2015-11-01 |
| TWI611184B TWI611184B (en) | 2018-01-11 |
Family
ID=55220455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW103114412A TWI611184B (en) | 2014-04-21 | 2014-04-21 | Method for using health indicator |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI611184B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113329622A (en) * | 2018-11-30 | 2021-08-31 | 惠托斯饲料添加剂股份有限公司 | System for analyzing animal waste images |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5764558B2 (en) * | 2011-02-28 | 2015-08-19 | 株式会社大貴 | Water absorption treatment material |
-
2014
- 2014-04-21 TW TW103114412A patent/TWI611184B/en not_active IP Right Cessation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113329622A (en) * | 2018-11-30 | 2021-08-31 | 惠托斯饲料添加剂股份有限公司 | System for analyzing animal waste images |
| CN113329622B (en) * | 2018-11-30 | 2023-01-10 | 惠托斯饲料添加剂股份有限公司 | System for analyzing animal waste images |
Also Published As
| Publication number | Publication date |
|---|---|
| TWI611184B (en) | 2018-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Šikić Pogačar et al. | Diagnosis and management of diaper dermatitis in infants with emphasis on skin microbiota in the diaper area | |
| Toppari et al. | Trends in puberty timing in humans and environmental modifiers | |
| Wagenlehner et al. | A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis–chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study | |
| AU2015399329B2 (en) | Devices and methods for drug administration and mixing, and training of proper techniques therefor | |
| Nayak et al. | Gastroretentive hydrodynamically balanced systems of ofloxacin: In vitro evaluation | |
| Stenman et al. | Genetically obese mice do not show increased gut permeability or faecal bile acid hydrophobicity | |
| Hsieh et al. | In utero exposure to benzophenone-2 causes hypospadias through an estrogen receptor dependent mechanism | |
| Braun et al. | Clinical and laboratory findings, treatment and outcome in 145 cows with type-2 abomasal ulcer | |
| TWI611184B (en) | Method for using health indicator | |
| El Baz et al. | Clinical and parasitological studies on the efficacy of Mirazid in treatment of schistosomiasis haematobium in Tatoon, Etsa Center, El Fayoum Governorate | |
| JP2011219449A (en) | Inflammatory bowel disease therapeutic agent | |
| McHugh et al. | Assessment and management of gastrointestinal symptoms in advanced illness | |
| Akkouche et al. | Autochthonous hookworm-related cutaneous larva migrans disease in Northeastern Italy: A case report | |
| Kanoksil et al. | Endoscopic removal of one live biliary Fasciola gigantica | |
| Lim et al. | The significance of fecal immunochemical test to screen for colorectal cancer in national cancer screening program | |
| Poovorawan et al. | Liver Fluke Infections | |
| Kudo et al. | Digestive Diseases | |
| Musik et al. | Comparison of the influence of selenium supplementation in organic and inorganic forms on oxidant/antioxidant balance in rat lungs | |
| Alemdar | Chronobiological treatment approach in COVID-19 | |
| Li et al. | Expression of Wnt5a during development of anorectal malformations in a rat model of prenatal exposure to di (n-butyl) phthalate | |
| Milde et al. | Intestinal permeability and faecal Granulocyte Marker Protein in Dextran Sulphate Sodium-induced colitis in rats | |
| Mamadumarov | Prevalence and features of dyslipidemia in different populations depending on race/ethnicity, gender and age | |
| Teaching Assistant et al. | Post Typhoid Ileum Perforation | |
| Yu et al. | Viper's blood and bile | |
| Tafese | ADDIS ABABA SCHOOL OF GRAD |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |